Group One Trading
AVNR

Group One Trading’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Group One Trading’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-722,900
Closed -$12.3M – 5694
2014
Q4 		$12.3M Buy
722,900
+147,800
+26% +$2.08M 0.18% 98
2014
Q3 		$6.86M Buy
575,100
+346,300
+151% +$2.36M 0.11% 200
2014
Q2 		$1.29M Sell
228,800
-35,200
-13% -$162K 0.02% 972
2014
Q1 		$969K Buy
264,000
+86,800
+49% +$331K 0.02% 1119
2013
Q4 		$595K Buy
177,200
+129,000
+268% +$533K 0.01% 1536
2013
Q3 		$204K Buy
48,200
+14,700
+44% +$69.7K ﹤0.01% 2367
2013
Q2 		$154K Buy
+33,500
New +$115K ﹤0.01% 2404

Group One Trading's AVNR Position: Q1 2015 in Review

Group One Trading sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,607 shares — an estimated $27K sold.

Group One Trading first reported a position in AVNR in Q2 2013 and held it in 6 quarters. The position peaked at $4.73M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Group One Trading reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Group One Trading sold 1,607 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $27K.
  • Group One Trading first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 6 quarters.
  • Group One Trading's AVANIR PHARMACEUTICALS, INC CL A position peaked at $4.73M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Group One Trading's 13F filing for Q1 2015, filed 14 May 2015.